Germany and France pay the price for AstraZeneca’s excitement as citizens EXPLAINS Oxford injection

Germany and France pay the price for their AstraZeneca uprising as citizens EXPLAIN Oxford injection, causing further delays to their shambolic vaccine drivers

  • Thousands of them are deliberately skipping meetings for the Oxford injection in Europe
  • Leaders feared it was ‘semi-ineffective’, leading to low uptake
  • Germany and France have only vaccinated six per cent of their population

People in Germany and France are refusing to take the Oxford AstraZeneca vaccine after their leaders warned of its effectiveness.

Only 150,000 out of 1.5 million doses of the injection were used in Germany on Friday, with many jumping deliberately after learning they would receive the Oxford vaccine.

Politicians across Europe, including Emmanuel Macron, fear the vaccine is ‘semi-ineffective’ among people over 65, despite little data to support this. and many health authorities allow its use.

Germany and France have vaccinated just six per cent of their population, and the UK has given doses to more than 26 per cent of people

Politicians across Europe, including Emmanuel Macron, fear the 'semi-effective' vaccine among people over 65

Politicians across Europe, including Emmanuel Macron, fear the ‘semi-effective’ vaccine among people over 65

People in Germany and France are refusing to take the Oxford AstraZeneca vaccine after their leaders Macron and Angela Merkel warned of its effectiveness

People in Germany and France are refusing to take the Oxford AstraZeneca vaccine after their leaders Macron and Angela Merkel warned of its effectiveness

But leaders are now urging people to inject Oxford, with the lack of uptake threatening to eradicate Europe’s vaccine spread, which is still far behind across the UK.

Germany and France have vaccinated just six per cent of their population, and the UK has given doses to more than 26 per cent of people.

In Berlin, the Tegel vaccine centers, which offer only the AstraZeneca jabs, say 200 people hold the 3,800 daily meetings, The Times reported.

In France, health workers have also been refusing the vaccine following Macron’s comments during the warm-up series about its effectiveness.

But leaders are now urging people to take the Oxford injection, with the lack of uptake threatening to eradicate Europe's vaccine spread, which is still far behind across the UK

But leaders are now urging people to take the Oxford injection, with the lack of uptake threatening to eradicate Europe’s vaccine spread, which is still far behind across the UK

The European Medicines Agency has approved it for all adults but Germany has ruled that it should not be given to people over 65.

It is only given to health care workers and people under 65 with pre-existing conditions.

There are now growing rumors in Europe that an Oxford injection will be given to anyone who wants it so that the filters are not worn.

Karl Lauterbach, an epidemiologist and Social Democrat MP in Germany, said: ‘The vaccine booths are ready, the vaccine is there and so are the vaccination teams.

‘But the vaccine remains unused as not enough people show up for the meeting. This is an unusual and inaccessible situation. ‘

Berlin mayor Michael Muller has threatened to put people behind the vaccine queue if they refuse an Oxford injection for Pfizer.

In Berlin, the Tegel vaccine centers (pictured), which offer only the AstraZeneca jabs, say 200 people hold the 3,800 daily meetings

In Berlin, the Tegel vaccine centers (pictured), which offer only the AstraZeneca jabs, say 200 people hold the 3,800 daily meetings

He told Tageepiegel: ‘I will not allow tens of thousands of doses to lie around our shelves while millions of people across the country are waiting for vaccinations.’

German health minister Jens Spahn also backed the injection, saying it was a ‘benefit’ to offer injections with the ‘safe and effective’ British vaccine.

Other countries including Spain, Hungary, Sweden and Norway have also suggested that they do not give the injection to anyone over 65.

Scientists admit that a lack of data conclusively confirms that the vaccine works for older people but the data they have show that it does not affect them less than it does for older people. childhood, in which it has been proven to inhibit Covid-19.

Boris Johnson had previously said he was not worried about the movement of European countries, adding that the famous UK governor had ‘made it clear’ that the bullet was ‘very good and effective’.

The question raised by European countries with the study is that the vaccine has only been tried on 660 people over the age of 65 in results published so far.

.Source